Eyepoint Pharmaceuticals Inc
Ownership
Ownership Structure
Who owns Eyepoint Pharmaceuticals Inc (EYPT)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 70.4% of the shares are freely tradable; institutional investors hold 111.8%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Suvretta Capital Management, LLC | 9.62 | 8,296,375 | +6.0 | 03/31/2026 |
| Cormorant Asset Management, LLC | 9.59 | 8,265,000 | +0.0 | 03/31/2026 |
| BlackRock Inc | 8.33 | 7,177,337 | +5.7 | 03/31/2026 |
| Federated Hermes Inc | 6.59 | 5,681,052 | +0.2 | 06/30/2026 |
| Franklin Templeton Inc | 5.86 | 5,048,598 | +1.4 | 03/31/2026 |
| Adage Capital Partners Gp LLC | 5.60 | 4,827,792 | +46.3 | 06/30/2026 |
| HHG PLC | 4.18 | 3,601,168 | +22.6 | 03/31/2026 |
| Vanguard Capital Management, LLC | 4.13 | 3,559,569 | +0.0 | 03/31/2026 |
| Paradigm Biocapital Advisors LP | 3.35 | 2,890,397 | -8.0 | 06/30/2026 |
| COMMODORE CAPITAL LP | 3.28 | 2,825,000 | +0.0 | 03/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Elston George | Chief Financial Officer | 161,644 | 630,412 $ | Aug 20, 2026 | both |
| Zaderej Karen L. | Director | 49,100 | 191,490 $ | Aug 18, 2026 | direct |
| Duker Jay S. | President and CEO | 9,594 | 37,417 $ | Jul 10, 2026 | direct |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 20, 2026 | Elston George | Chief Financial Officer | Other | 64,953 | 0.00 | – |
| Aug 20, 2026 | Elston George | Chief Financial Officer | Other | 5,000 | 0.00 | – |
| Aug 18, 2026 | Zaderej Karen L. | Director | Buy | 10,600 | 4.93 | 52,258 |
| Jul 10, 2026 | Duker Jay S. | President and CEO | Other | 8,059 | 14.72 | 118,628 |
| Jul 10, 2026 | Duker Jay S. | President and CEO | Other | 16,667 | 0.00 | – |
| Apr 17, 2026 | Ramiro Ribeiro | Insider | Sell | 2,437 | 15.00 | 36,555 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.